Ubs Group Ag Coh Bar, Inc. Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022
BUY
$0.17 - $0.34 $4,767 - $9,535
28,047 Added 919.27%
31,098 $6,000
Q1 2022

May 16, 2022
BUY
$0.25 - $0.43 $762 - $1,311
3,051 New
3,051 $1,000
Q4 2021

Feb 14, 2022
SELL
$0.34 - $1.0 $7,181 - $21,123
-21,123 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$0.96 - $1.62 $14,511 - $24,487
15,116 Added 251.64%
21,123 $20,000
Q2 2021

Aug 13, 2021
SELL
$1.09 - $1.49 $7,868 - $10,756
-7,219 Reduced 54.58%
6,007 $8,000
Q1 2021

May 12, 2021
BUY
$1.26 - $2.02 $1,847 - $2,961
1,466 Added 12.47%
13,226 $18,000
Q4 2020

Feb 11, 2021
BUY
$0.9 - $1.54 $7,539 - $12,900
8,377 Added 247.62%
11,760 $15,000
Q3 2020

Nov 12, 2020
SELL
$0.87 - $2.08 $5,224 - $12,490
-6,005 Reduced 63.96%
3,383 $3,000
Q2 2020

Jul 31, 2020
BUY
$1.08 - $4.0 $9,059 - $33,552
8,388 Added 838.8%
9,388 $15,000
Q1 2020

May 01, 2020
SELL
$1.01 - $2.74 $1,354 - $3,674
-1,341 Reduced 57.28%
1,000 $1,000
Q4 2019

Feb 14, 2020
BUY
$1.2 - $2.34 $1,609 - $3,137
1,341 Added 134.1%
2,341 $4,000
Q3 2019

Nov 14, 2019
SELL
$1.3 - $1.76 $7,777 - $10,530
-5,983 Reduced 85.68%
1,000 $1,000
Q2 2019

Aug 14, 2019
BUY
$1.63 - $3.3 $1,602 - $3,243
983 Added 16.38%
6,983 $12,000
Q1 2019

May 14, 2019
SELL
$2.95 - $4.16 $41,058 - $57,898
-13,918 Reduced 69.88%
6,000 $20,000
Q4 2018

Feb 14, 2019
BUY
$2.97 - $4.52 $24,163 - $36,774
8,136 Added 69.05%
19,918 $62,000
Q3 2018

Nov 14, 2018
BUY
$4.13 - $6.84 $17,263 - $28,591
4,180 Added 54.99%
11,782 $51,000
Q2 2018

Aug 14, 2018
BUY
$4.44 - $10.4 $27,963 - $65,499
6,298 Added 482.98%
7,602 $50,000
Q1 2018

May 15, 2018
BUY
$4.85 - $6.92 $6,324 - $9,023
1,304 New
1,304 $7,000

Others Institutions Holding CWBR

# of Institutions
1
Shares Held
1.14K
Call Options Held
0
Put Options Held
0
View Full List

About CohBar, Inc.

CWBR Quotes by TradingView
  • Ticker CWBR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,906,940
  • Market Cap $1.57M
  • Description
  • CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...
More about CWBR
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email